Drug class in one race
GLP-1/GIP/glucagon receptor (triple) drugs for Obesity
6 tracked GLP-1/GIP/glucagon receptor (triple) drugs in the Obesity race. The class explanation lives on the GLP-1/GIP/glucagon receptor (triple) page; the full indication pipeline across every mechanism is on the Obesity page.
2 Phase 33 Phase 21 Phase 1
Head-to-head evidence: HM15211 vs HM15275 · HM15211 vs HRS-4729 · HM15211 vs NNC0662-0419 · HM15211 vs UBT251 · HM15211 vs retatrutide · HM15275 vs HRS-4729